Moreover, low-dose BTZ injection mainly prevented Th2 cytokine expression, including IFN-γ, TNF-α, IL-4, IL-6 and MCP-1 in Ang II-induced AAA, presumably by blocking NF-κB signaling pathway39 (Fig. 5d). This evidence concerns the gene IL6 and triple-A syndrome.